Skip to content

Comparison of remimazolam and volatile anesthetics on perioperative hypothermia in patients undergoing general anesthesia

Comparison of remimazolam and volatile anesthetics on perioperative hypothermia in patients undergoing general anesthesia for nasal surgery: A prospective randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0006838
Enrollment
70
Registered
2021-12-17
Start date
2021-12-24
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Sponsors

Konyang University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective nasal surgery of otolaryngology under general anesthesia 2. Patients in class I and II according to the American Society of Anesthesiologists physical status classification 3. Age 19-65

Exclusion criteria

Exclusion criteria: - The body temperature measured in the ward before surgery is 37.6°C or higher or less than 36.0°C -obesity (BMI >35kg/m2) - patients who are less than 19 years old, 66 years old or older -Emergency surgery -Hemodynamic instability or respiratory failure - In case of contraindications to the use of remimazolam (ex. hypersensitivity to benzodiazepine drugs, glaucoma, alcohol or drug dependence, sleep apnea syndrome, renal failure, liver failure, etc.) -psychiatric history and cognitive impairment -In case of the time from induction of anesthesia to termination of anesthesia is less than 1 hour

Design outcomes

Primary

MeasureTime frame
incidence rate of postoperative hypothermia

Secondary

MeasureTime frame
Difference in core body temperature before and after surgery

Countries

Korea, Republic of

Contacts

Public ContactSung-Ae Cho

Konyang University Hospital

sachosa@naver.com+82-42-600-9301

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026